Genmab is revamping its executive team as the Danish antibody specialist expands its commercialization efforts and looks to evolve into “a fully integrated biotech innovation powerhouse.” Genmab’s ...
The previous chapter provided descriptive evidence around the landscape of SBIR/STTR winners. This report now turns to the observable impact of the DOE SBIR/STTR programs on key dimensions of ...
This article explores the steps taken to commercializing flexible hybrid electronics, including an example of an FHE solution that has already come on to the market. The starting point for roadmaps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results